Trials / Unknown
UnknownNCT04380064
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Tractional Retinal Detachment: a Randomized Clinical Trial
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Rush Eye Associates · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Subject/Participant Groups: Study Group: Subjects undergo internal limiting membrane (ILM) peeling during vitrectomy for the indication of tractional retinal detachment Control Group: Subjects do not undergo ILM peeling during vitrectomy for the indication of tractional retinal detachment
Detailed description
Hypothesis: Subjects undergoing ILM peeling during vitrectomy will have lower central macular thickness on OCT, fewer postoperative epiretinal membranes, and thereby better final visual acuity to control subjects Randomization: Subjects will be randomized according to a coin toss during PPV, once Grade 2 or Grade 3 vitreoretinal adhesion has been determined: heads undergo ILM peeling, while tails do not. Number of Subjects: With study power of 80%, a significance level of 0.05, a sample size of 60 patients for each group was calculated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ILM Peeling | ILM peeling performed during primary PPV for PDR |
| PROCEDURE | No ILM Peeling | ILM peeling not performed during primary PPV for PDR |
Timeline
- Start date
- 2020-05-01
- Primary completion
- 2025-02-01
- Completion
- 2025-02-01
- First posted
- 2020-05-08
- Last updated
- 2023-11-18
Locations
1 site across 1 country: Mexico
Source: ClinicalTrials.gov record NCT04380064. Inclusion in this directory is not an endorsement.